Jump to content

Fda Issues Guidance for Industry on Wholesale Distributor Verification Requirement for Saleable Returned Drug Product

24th September 2019

On the 23rd September, FDA announced the availability of a final guidance for industry entitled "Wholesale Distributor Verification Requirement for Saleable Returned Drug Product--Compliance Policy."  

This guidance announces FDA’s compliance policy regarding the Drug Supply Chain Security Act (DSCSA) provision requiring wholesale distributors to verify a product identifier prior to further distributing returned drug products.

Click here for more.

Back to Recent News

Share